Molecular Med TRI-CON 2017

The Molecular Med TRI-CON 2017 conference event will be held February 19-24, 2017 in San Francisco, California.

This annual event focuses on molecular medicine research and methodologies, including discovery, genomics, diagnostics and information technology.

TRI-CON draws more than 3,500 drug discovery and development professionals and features 400+ sessions.

Main Conference Tracks Feb 20-22 include:

• Molecular Diagnostics
• Personalized Diagnostics
• Cancer Molecular Markers
• Circulating Tumor Cells and
• Liquid Biopsy
• Digital Pathology
• Precision Medicine
• PCR and NGS-Based Molecular Diagnostics
• Clinical NGS Diagnostics
• Genomic Sample Prep, Assay Development and Validation
• Molecular Diagnostics for Infectious Disease
• Cancer Immunotherapy
• Combination Immunotherapy Design Models
• Bioinformatics for Big Data
• Integrated Pharma Informatics

Symposia Tracks Feb 22-24 include:

• New Frontiers in CRISPR-Based Gene Editing
• Circulating Cell-Free DNA
• Point-of-Care Diagnostics
• Biomarkers for Cancer Immunotherapy
• NGS Diagnostics: Knowledge Bases, Annotation and Interpretation
• Microbiome-Based Precision Medicine – New
• Commercialization of Molecular Diagnostics

Please visit the Molecular Med TRI-CON 2017 website for more information and to register.

Global Biodefense is an official media partner of Molecular Med TRI-CON 2017.